MedTrace Logo

Abdominal Wall Local Anesthesia to Maximize Postoperative Pain Control After Cesarean Delivery

NCT01261637 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2013-05-23

No results posted yet for this study

Summary

This study has been designed to determine if women undergoing cesarean delivery with spinal anesthesia and routine pain management who also have an additional ultrasound guided transversus abdominis plane (TAP)block using ropivacaine have better pain relief and a better quality of recovery than women who don't have the additional TAP block. Maximizing pain relief using ultrasound guided TAP blocks in addition to neuraxial opioids, NSAIDs, and acetaminophen may improve acute pain outcomes, reduce adverse side effects, and potentially reduce chronic pain.

Conditions

  • Postoperative Pain

Interventions

DRUG

Saline placebo

20ml saline

DRUG

Ropivicaine

0.25% ropivicaine (maximum 1.5mg/kg)

Sponsors & Collaborators

  • IWK Health Centre

    lead OTHER

Principal Investigators

  • Dolores McKeen, MD MSc FRCPC · IWK Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-07-31
Completion
2011-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01261637 on ClinicalTrials.gov